Buten Matthew
CIK 0001898799
Chief Financial Officer
Filings
8
Latest Mar 3, 2026
Issuers covered
2
Showing
8 of 8
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +19.5% | +19.5% | +19.5% | +19.5% |
| 90 days | 1 | 100% | +66.4% | +66.4% | +66.4% | +66.4% |
| 180 days | 1 | 100% | +110.3% | +110.3% | +110.3% | +110.3% |
| 365 days | 1 | 100% | +97.2% | +97.2% | +97.2% | +97.2% |
Issuers
Companies where Buten Matthew has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BHVN | Biohaven Ltd. | 6 | Mar 3, 2026 |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | 2 | Jan 7, 2022 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|